Compare TIMB & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TIMB | TXG |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 9.3B |
| IPO Year | 2020 | 2019 |
| Metric | TIMB | TXG |
|---|---|---|
| Price | $19.00 | $59.11 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 17 |
| Target Price | $22.78 | ★ $68.14 |
| AVG Volume (30 Days) | 838.2K | ★ 3.2M |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | ★ 5.99% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | $5.35 | N/A |
| Revenue Next Year | $4.18 | $11.72 |
| P/E Ratio | $15.81 | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $15.94 | $15.12 |
| 52 Week High | $28.22 | $102.81 |
| Indicator | TIMB | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 56.18 | 40.03 |
| Support Level | $17.37 | $56.98 |
| Resistance Level | $19.58 | $63.82 |
| Average True Range (ATR) | 0.64 | 6.47 |
| MACD | 0.14 | -1.08 |
| Stochastic Oscillator | 80.03 | 17.58 |
TIM, which is 67%-owned by Telecom Italia, is the third-largest wireless carrier in Brazil, with 62 million subscribers, equal to about 23% of the market. The firm owns 49% of I-Systems, an infrastructure partnership that is expanding its network footprint across Brazil. I-Systems can provide broadband service to about 8 million locations, including 6.5 million with fiber, equal to 10%-15% of the country. TIM leases capacity on the venture's network to serve retail broadband customers under the UltraFibra brand, but it has agreed to buy out its joint venture partner in 2026 and will take full ownership of these assets. TIM also resells fiber network access from other providers.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).